MHC’s mission is to develop and support legislative, regulatory, and other policies that encourage psychedelic research, education, and clinical trials in Missouri. This path will allow MHC to identify benefits and treatments for veterans, first responders and others struggling with unmet medical needs.
Modern Health Coalition Initiatives
MHC is committed to advancing evidence-based psychedelic research and shaping policies that expand access to life-changing mental health treatments in Missouri. Our key initiatives include advocating for groundbreaking legislation, securing funding for clinical research, and educating policymakers and the public on the potential of psychedelic-assisted therapies.
We are at the forefront of a movement to transform mental health care for Veterans, first responders, and all those in need.
Building on these results, more federal research is needed through the Veterans Administration, the Department of Defense and the National Institutes for Health. We will advocate for increased funding in these areas
Why New Approaches to Medicine?
We are at the intersection of science, regulation, and entrepreneurship that is just beginning to understand how to best integrate these new medicines in healthcare. There is a wave of activity right now but, as always, with excitement comes the need for caution. These therapies need to come to market in a regulated way. We believe in the power that policy, science, and clinical trials must bring new treatments to the patients who need it most.
Advocacy momentum has led to scientific research has steadily been gaining momentum with early data being promising. The data shows these compounds can be safe, well tolerated, and, when used in the right set and setting, show promise to treat some of the most challenging therapeutic indications such as PTSD, anxiety, addiction, and depression.